CMPD.US CompuMed Inc
- Market cap
- USD 7.26M
- P/E
- -
- P/B
- 36.30x
- ROE
- -3.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is CMPD.US undervalued?
Graham numberThe Graham number of CompuMed Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CompuMed Inc fundamental analysis
No fundamental analysis for CompuMed Inc yet.
CompuMed Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CompuMed Inc
CompuMed, Inc. provides diagnostic telemedicine solutions in the United States. It offers a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including echocardiogram, ECG/EKG, nuclear cardiology, cardiac CT and MRI, MUGA scan, cardiac catheterization, pediatric, stress testing, and holter/event monitor; and teleradiology reading and interpretation services, such as X-ray, ultrasound, chest CT, MRI, measurement, and on dem…
Full company profileCompuMed Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CompuMed Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.10M | 2.31M | 3.52M | 5.05M | 5.27M | 6.32M | 6.37M | 5.84M | 6.22M | 7.55M | 8.38M |
| Gross Profit | 786K | 1.12M | 1.69M | 2.62M | 2.77M | 3.35M | 3.30M | 2.89M | 3.02M | 3.58M | 4.06M |
| Operating Income | -118K | 91.2K | 228K | 994K | 395K | 1.01M | 550K | -31.2K | 205K | -16.6K | -78.0K |
| EBITDA | 128K | 166K | 399K | 1.27M | 629K | 1.48M | 1.12M | 690K | 952K | 808K | 709K |
| Net Income | -134K | 84.9K | 219K | 974K | 338K | 1.07M | 502K | -32.6K | 193K | -64.2K | -112K |
| EPS | -0.11 | 0.07 | 0.17 | 0.75 | 0.26 | 0.69 | 0.30 | -0.02 | 0.15 | -0.05 | -0.09 |
| Balance Sheet | |||||||||||
| Total Assets | 623K | 835K | 1.52M | 2.91M | 4.10M | 5.13M | 5.35M | 4.44M | 4.62M | 5.01M | 4.79M |
| Total Liabilities | 305K | 404K | 705K | 1.06M | 1.82M | 1.77M | 1.50M | 1.35M | 1.34M | 1.91M | 1.76M |
| Shareholders' Equity | 318K | 431K | 815K | 1.85M | 2.28M | 3.36M | 3.85M | 3.09M | 3.28M | 3.10M | 3.03M |
| Cash & Short-term Investments | 126K | 253K | 300K | 1.18M | 1.89M | 2.21M | 1.80M | 1.08M | 1.56M | 1.65M | 1.84M |
| Total Debt | 38.2K | 46.9K | 46.1K | 509K | 1.09M | 765K | 538K | 393K | 523K | 714K | 546K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 199K | 175K | 492K | 953K | 1.07M | 1.42M | 736K | 520K | 877K | 1.25M | 487K |
| Capital Expenditure | 76.0K | 57.2K | 420K | 532K | 795K | 882K | 909K | 370K | 522K | 1.23M | 33.3K |
| Free Cash Flow | 123K | 118K | 72.2K | 422K | 271K | 537K | -173K | 150K | 355K | 19.9K | 453K |
| Ratios | |||||||||||
| ROE | -42.3% | 19.7% | 26.9% | 52.6% | 14.8% | 31.8% | 13.0% | -1.1% | 5.9% | -2.1% | -3.7% |
| ROA | -21.6% | 10.2% | 14.4% | 33.5% | 8.3% | 20.8% | 9.4% | -0.7% | 4.2% | -1.3% | -2.3% |
| Net Profit Margin | -6.4% | 3.7% | 6.2% | 19.3% | 6.4% | 16.9% | 7.9% | -0.6% | 3.1% | -0.9% | -1.3% |
| Debt to Equity | 0.12x | 0.11x | 0.06x | 0.28x | 0.48x | 0.23x | 0.14x | 0.13x | 0.16x | 0.23x | 0.18x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CompuMed Inc dividends
CompuMed Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:25 on May 23, 2022.
Who owns CompuMed Inc
Ownership data of CompuMed Inc is not available yet.
CompuMed Inc company profile
- Company name
- CompuMed Inc
- Ticker
- CMPD.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 8
- Fiscal year end
- September
- Address
- 5777 West Century Blvd., Los Angeles, CA, United States, 90045
- Phone
- 310 258 5000
- Website
- compumedinc.com
About CompuMed Inc
CompuMed, Inc. provides diagnostic telemedicine solutions in the United States. It offers a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including echocardiogram, ECG/EKG, nuclear cardiology, cardiac CT and MRI, MUGA scan, cardiac catheterization, pediatric, stress testing, and holter/event monitor; and teleradiology reading and interpretation services, such as X-ray, ultrasound, chest CT, MRI, measurement, and on demand consult. The company also provides telepathology reading and interpretation services for liver, renal/kidney, pancreas, and tissue; and pulmonology reading and interpretation services comprising bronchoscopy, 3D rendering, measurement, and lung management. In addition, it provides support services; and operates CompuMed, a cloud-based portal that allows to view, manage, and share your case data. The company serves organ donation/transplant, correctional healthcare, hospitals, and rural hospital telemedicine medicines. CompuMed, Inc. was incorporated in 1986 and is headquartered in Los Angeles, California.
CompuMed Inc management
2- Mr. Lee KeddieCEO, President & Director
- Ms. Laura CarrollCFO, Secretary & Director